Kamalinder K Singh

Kamalinder K Singh is a Professor of Pharmaceutical Technology and Drug Delivery at the University of Central Lancashire, School of Pharmacy and Biomedical Sciences. She serves as the Research and Knowledge Exchange Lead for the School. Her research focuses on nanomedicine and advanced drug delivery systems, with a strong emphasis on translational applications in healthcare. Professor Singh has led over 40 funded research projects as Principal Investigator, securing grants from institutions like the NIH, Academy of Medical Sciences, and the British Council. Her work spans drug delivery mechanisms for challenging diseases such as malaria, cancer, and neurological disorders.

Research Interests: Her expertise lies in nanotechnology-driven drug delivery, including lipid-based nanocarriers, targeted therapies for the blood-brain barrier, and innovative solutions for skin and ocular diseases. She also explores phytomedicines and their integration with nanotechnology to overcome treatment limitations.

Articles Overview: Recent publications highlight advancements in receptor-mediated nanotherapeutics, malaria therapy using plant-based nanomedicines, and functionalized lipid carriers for glioblastoma treatment. Her work consistently bridges fundamental science with clinical applications, emphasizing translational outcomes.

Grants & Leadership: Professor Singh has managed grants totaling millions, including NIH-funded projects on nanocarrier design and AMS-supported studies on targeted drug delivery. Her leadership extends to collaborative international projects, particularly in developing countries.

Teams & Initiatives: She leads multidisciplinary teams within UCLan’s research centers, fostering innovation in pharmaceutical technology and drug delivery. Her lab’s work has significant impact on global health challenges, particularly in resource-limited settings.